论文部分内容阅读
目的分析丙酸氟替卡松气雾剂吸入治疗小儿肺炎支原体感染所致慢性咳嗽的临床效果。方法选取本院儿科收治的因肺炎支原体感染所致慢性咳嗽婴幼儿120例,随机分为实验组、对照组各60例,两组均给予阿奇霉素抗感染治疗,实验组另给予丙酸氟替卡松气雾剂吸入治疗。观察两组用药后,咳嗽、呼吸急促缓解时间、肺部啰音消失时间及3月内慢性咳嗽反复发作次数。结果实验组明显优于对照组,差异有统计学意义(P<0.05),但治疗后体温恢复时间两组间比较则无统计学差异(P>0.05)。结论丙酸氟替卡松气雾剂治疗婴幼儿肺炎支原体感染致慢性咳嗽,疗效显著。
Objective To analyze the clinical effect of inhalation of fluticasone propionate aerosol in treating chronic cough caused by Mycoplasma pneumoniae infection in children. Methods A total of 120 children with chronic cough caused by Mycoplasma pneumoniae infection in our hospital were randomly divided into experimental group and control group with 60 cases in each group. Azithromycin was given anti-infective therapy in both groups. In the experimental group, fluticasone propionate aerosol Inhalation therapy. After the two groups were treated, the time of cough, shortness of breath, the disappearance of pulmonary rales and the number of recurrent chronic cough within 3 months were observed. Results The experimental group was significantly better than the control group, the difference was statistically significant (P <0.05), but after treatment, the body temperature recovery time between the two groups showed no significant difference (P> 0.05). Conclusion Fluticasone propionate aerosol treatment of infantile Mycoplasma pneumoniae infection caused by chronic cough, a significant effect.